FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096360 [Registered on: 22/10/2025] Trial Registered Prospectively
Last Modified On: 21/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study to see if gentle electrical stimulation machine on the head and daily time-based exercises can help reduce tiredness, anxiety, and depression in women with breast cancer who are getting chemotherapy. 
Scientific Title of Study   Transcranial Direct Current Stimulation(tDCS) and Circadian Rhythm Time-Based Conventional Exercises for Fatigue, Anxiety and Depression in Breast Cancer patients undergoing chemotherapy:A Single-Blind Randomized Controlled Trial. 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Simran Kaur Ram Prakash Singh Rahanu 
Designation  Post Graduate Student 
Affiliation  KAHER Institute of Physiotherapy 
Address  Advanced Physiotherapy Centre, Room no.39, opd no.19, Neurology Physiotherapy Department, KLES Dr.Prabhakar Kore Hospital and Medical Research Centre, Nehru Nagar, Karnataka 590010 Belgaum India.

Belgaum
KARNATAKA
590010
India 
Phone  08850471245  
Fax    
Email  rahanusimrankaur99@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sanjiv Kumar 
Designation  MPT, PHD,FIAP Professor Department of Neurology Physiotherapy. 
Affiliation  KAHER Institute of Physiotherapy 
Address  Advanced Physiotherapy Centre,Room no.39, opd no.19,Neurology Physiotherapy Department, KLES Dr.Prabhakar Kore Hospital and Medical Research Centre, Nehru Nagar, Karnataka 590010 Belgaum India.

Belgaum
KARNATAKA
590010
India 
Phone  9448745648  
Fax    
Email  sanjiv3303@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sanjiv Kumar 
Designation  MPT, PHD,FIAP Professor Department of Neurology Physiotherapy. 
Affiliation  KAHER Institute of Physiotherapy 
Address  Advanced Physiotherapy Centre,Room no.39, opd no.19,Neurology Physiotherapy Department, KLES Dr.Prabhakar Kore Hospital and Medical Research Centre, Nehru Nagar, Karnataka 590010 Belgaum India.

Belgaum
KARNATAKA
590010
India 
Phone  9448745648  
Fax    
Email  sanjiv3303@rediffmail.com  
 
Source of Monetary or Material Support  
KAHER Institute of Physiotherapy, Nehru Nagar, Belagavi- 590010 
 
Primary Sponsor  
Name  Simran Kaur Ram Prakash Singh Rahanu 
Address  Advanced Physiotherapy Centre,Room no.39, opd no.19,Neurology Physiotherapy Department, KLES Dr.Prabhakar Kore Hospital and Medical Research Centre, Nehru Nagar, Karnataka 590010 Belgaum India. 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Simran Kaur Ram Prakash Singh Rahanu  KLES Dr.Prabhakar Kore Hospital and Medical Research Centre  Advanced Physiotherapy Centre,Room no.39, opd no.19,Neurology Physiotherapy Department, KLES Dr.Prabhakar Kore Hospital and Medical Research Centre, Nehru Nagar, Belagavi, Karnataka 590010 Belgaum India.
Belgaum
KARNATAKA 
8850471245

rahanusimrankaur99@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
KLE ACADEMY OF HIGHER EDUCATION AND RESEARCH  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C509||Malignant neoplasm of breast of unspecified site,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  sham tDCS with circadian rhythm time -based exercises  Participants will receive sham tDCS for 4 weeks 5 sessions per week with identical electrode placement and parameters; the current will be ramped up for 30 seconds and then turned off to mimic sensations of stimulation.The exercise program combines daily aerobic walking and resistance band training to reduce fatigue and maintain strength. Exercises are performed 7 days/week for 4 weeks at moderate intensity (60–70% HRR). The walking goal is to increase daily steps by 5–20% each week toward 10,000 steps/day. Resistance training includes 11 upper-body movements (e.g., curls, presses, rows), beginning with 1 set × 8–15 repetitions and progressing up to 4 sets.The intervention time was specifically set between 8:30 and 9:30 a.m 
Intervention  tDCS with circadian rhythm time-based exercises  Participants will receive active tDCS over the dorsolateral prefrontal cortex (DLPFC) at 2 mA for 20 minutes per session, 5 sessions per week for 4 weeks, using saline-soaked sponge electrodes (anode over left DLPFC [F3], cathode over right supraorbital region [Fp2]). The exercise program combines daily aerobic walking and resistance band training to reduce fatigue and maintain strength. Exercises are performed 7 days/week for 4 weeks at moderate intensity (60–70% HRR). The walking goal is to increase daily steps by 5–20% each week toward 10,000 steps/day. Resistance training includes 11 upper-body movements (e.g., curls, presses, rows), beginning with 1 set × 8–15 repetitions and progressing up to 4 sets. The routine is monitored and adjusted weekly.The intervention time was specifically set between 8:30 and 9:30 a.m 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Female 
Details  diagnosed with stage I–III breast cancer, scheduled to receive adjuvant or neoadjuvant chemotherapy, received approval from a medical oncologist to participate in the trial 
 
ExclusionCriteria 
Details  traumatic brain injury or concussion with residual
symptoms, mobility issues that require a mobility aid or an injury/illness that would prohibit exercising, self-reported physical or cognitive condition that prevented women from participating independently 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
FACIT-Fatigue scale
 
total 4 weeks of protocol,outcome will be assessed at baseline and after 4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Beck Anxiety Inventory
 
which will be assessed at baseline and after 4 weeks 
Beck Depression Inventory  which will be assessed at baseline and after 4 weeks  
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "36"
Final Enrollment numbers achieved (India)="36" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/11/2025 
Date of Study Completion (India) 19/02/2026 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This study involves breast cancer patients screened by inclusion and exclusion criteria. After obtaining written informed consent and demographic data, participants are randomly allocated by the envelope method into two groups—Group A receives active transcranial direct current stimulation (tDCS) combined with circadian rhythm time-based conventional exercises, while Group B receives sham tDCS with circadian rhythm time-based conventional exercises.

Pre-intervention and post-intervention assessments are conducted using fatigue anxiety and depression outcome measures. the FACIT-Fatigue scale  the Beck Anxiety Inventory (BAI) and Beck Depression Inventory . Both tDCS and the exercise interventions are administered by trained physiotherapists. The study aims to evaluate the efficacy of combining tDCS targeting fatigue with exercise timed to circadian rhythms on fatigue, anxiety and depression in breast cancer patients undergoing chemotherapy.

The intervention time was specifically set between 8:30 and 9:30 a.m., based on recommendations from the International Commission on Illumination and the WELL Building Standard, which suggest that adequate circadian stimulation in the morning.

This design allows controlled observation of the added effect of active tDCS over sham stimulation on fatigue anxiety and depression outcomes alongside standard exercise therapy, providing evidence for integrative rehabilitation approaches.




 
Close